Your browser doesn't support javascript.
loading
A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain Metastases.
Bi, Nan; Ma, Yuchao; Xiao, Jianping; Zhang, Hongmei; Xu, Yingjie; Tian, Yuan; Li, Junling; Zhang, Ye; Liu, Qingfeng; Wang, Kai; Deng, Lei; Wang, Wenqing; Chen, Xuesong; Liu, Feng; Zhao, Ruizhi; Yang, Siran; Huang, Xiaodong; Yi, Junlin; Hu, Chen; Li, Yexiong.
Afiliación
  • Bi N; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Ma Y; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Xiao J; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China jpxiao8@163.com.
  • Zhang H; Department of Radiology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Xu Y; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Tian Y; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Li J; Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Zhang Y; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Liu Q; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Wang K; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Deng L; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Wang W; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Chen X; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Liu F; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Zhao R; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Yang S; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Huang X; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Yi J; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Hu C; Division of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Li Y; Department of Radiation Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Oncologist ; 24(9): e914-e920, 2019 09.
Article en En | MEDLINE | ID: mdl-30996008
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Temozolomida Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Temozolomida Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article